Bookmark Article
The 2014 Ebola outbreak in west Africa highlighted the lack of effective vaccines, leading to the rVSV-ZEBOV trials in Guinea. The vaccine showed near-perfect efficacy and is now being used in Sierra Leone to target frontline workers. Challenges remain in ensuring equitable access and addressing vaccine hesitancy fueled by misinformation.
Full Article